Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för doramapimod. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2015-07-03

In vitro anti-osteoclastogenic activity of p38 inhibitor doramapimod via inhibiting migration of pre-osteoclasts and NFATc1 activity.

Moon SH, Choi SW, Kim SH.

J Pharmacol Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jphs.2015.06.008

Bibliografisk träff 2015-06-06

Characterization of interactions and pharmacophore development for DFG-out inhibitors to RET tyrosine kinase.

Gao C, Grøtli M, Eriksson LA.

J Mol Model · research support, non-u.s. gov't; journal article · DOI 10.1007/s00894-015-2708-z

Bibliografisk träff 2015-05-01

Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.

Lea S, Harbron C, Khan N, Booth G, Armstrong J, Singh D.

Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/bcp.12536

Bibliografisk träff 2014-09-29

Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases.

Dong J, Zhao H, Zhou T, Spiliotopoulos D, Rajendran C, Li XD, Huang D, Caflisch A.

ACS Med Chem Lett · rapid-communication; journal article · DOI 10.1021/ml500355x

Bibliografisk träff 2013-05-19

Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization.

Lavoie H, Thevakumaran N, Gavory G, Li JJ, Padeganeh A, Guiral S, Duchaine J, Mao DY, Bouvier M, Sicheri F, Therrien M.

Nat Chem Biol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/nchembio.1257

Bibliografisk träff 2010-07-23

X-ray crystal structure of JNK2 complexed with the p38alpha inhibitor BIRB796: insights into the rational design of DFG-out binding MAP kinase inhibitors.

Kuglstatter A, Ghate M, Tsing S, Villaseñor AG, Shaw D, Barnett JW, Browner MF.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2010.06.157

Bibliografisk träff 2009-02-25

Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.

Han S, Mistry A, Chang JS, Cunningham D, Griffor M, Bonnette PC, Wang H, Chrunyk BA, Aspnes GE, Walker DP, Brosius AD, Buckbinder L.

J Biol Chem · research-article; journal article · DOI 10.1074/jbc.m809038200

Bibliografisk träff 2002-04-01

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss N, Pav S, Regan J.

Nat Struct Biol · journal article · DOI 10.1038/nsb770